Avastin 25 mg/ml concentrate for solution for infusion., RANIBIZUMAB clinical trials

Multicentre, randomised, double-blind, parallel-group, Phase III study to evaluate the genetic polymorphisms influence in the response to Ranibizumab and Bevacizumab treatment in patients with Age-Associated Macular Degeneration

This study looks at how well two common eye medicines, ranibizumab and bevacizumab, work for people with Age-Related Macular Degeneration (AMD). Researchers are also checking if a person's genes affect how well these treatments work. The main goal is to see changes in eyesight after one year.